BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Chugai Pharmaceutical Co. reported, on a IFRS basis, nine month net income of 305.6 billion yen, up 3.3% from a year ago. Revenue was 911.6 billion yen, up 5.0%. On a core basis, net income was 320.0 billion yen, an increase of 6.2% from last year. Core revenue was 911.6 billion yen, up 5.0%.
The company said both domestic and overseas product sales performed steadily, resulting in increased revenue and profit year-over-year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
